Discontinuation report RAN-CITALO
| Report ID | 108127 |
| Drug Identification Number | 02285622 |
| Brand name | RAN-CITALO |
| Common or Proper name | CITALO |
| Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CITALOPRAM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-02-28 |
| Remaining supply date | 2020-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-03-07 | French | Compare |
| v1 | 2020-03-07 | English | Compare |
Showing 1 to 2 of 2